Thymidylate synthase structure, function and implication in drug discovery

被引:93
作者
Costi, MP
Ferrari, S
Venturelli, A
Caló, S
Tondi, D
Barlocco, D
机构
[1] Univ Modena & Reggio Emilia, Dipartimento Sci Farmaceut, I-41100 Modena, Italy
[2] Univ Milan, Ist Chim Farmaceut, I-20131 Milan, Italy
关键词
thymidylate synthase; biological pathways; structures; drug discovery;
D O I
10.2174/0929867054864868
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recent methodologies applied to the drug discovery process, such as genomics and proteomics, have greatly implemented our basic understanding of drug action and are giving more input to medicinal chemists, in finding genuinely new targets and opportunities for the development of drugs with original mechanisms of action. In this paper, an example of the successful application of some new techniques to the target enzymes with the Thymidylate Synthase (TS) function is given. The improved knowledge of the complex mechanism of the biological pathways in which thymidylate synthase is involved represents a unique chance to find new mechanism-based inhibitors, aimed to treat not only cancerous diseases, but also infectious pathologies. Thymidylate synthase (TS or ThyA) has long been considered as one of the best-known drug targets in the anti-cancer area, after which old and new drugs, such as 5-fluoro uracil and the anti-folate ZD1694, have been introduced into chemotherapy to treat solid tumours. Only a few attempts have been made to find non-classical anti-folate inhibitors that are dissimilar to the folate co-factor, with the aim of finding unshared protein target domains on the enzyme structure, in order to specifically inhibit TS enzymes from pathogens. Only recently from omic studies, a new Thymidylate Synthase Complementing Protein (TSCP or ThyX) has been identified in a number of pathogens, showing a different structure with respect to human TS, thus opening new avenues to specific inhibitions. A depiction of the most recent progress in the study of Thymidylate Synthase enzymes is presented in the following sections.
引用
收藏
页码:2241 / 2258
页数:18
相关论文
共 81 条
[51]   Design and synthesis of potent non-polyglutamatable quinazoline antifolate thymidylate synthase inhibitors [J].
Marsham, PR ;
Wardleworth, JM ;
Boyle, FT ;
Hennequin, LF ;
Kimbell, R ;
Brown, M ;
Jackman, AL .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (19) :3809-3820
[52]   Functional analysis of substrate and cofactor complex structures of a thymidylate synthase-complementing protein [J].
Mathews, II ;
Deacon, AM ;
Canaves, JM ;
McMullan, D ;
Lesley, SA ;
Agarwalla, S ;
Kuhn, P .
STRUCTURE, 2003, 11 (06) :677-690
[53]  
MEYERS CLF, 2000, J MED CHEM, V43, P2258
[54]   STRUCTURE, MULTIPLE SITE BINDING, AND SEGMENTAL ACCOMMODATION IN THYMIDYLATE SYNTHASE ON BINDING DUMP AND AN ANTIFOLATE [J].
MONTFORT, WR ;
PERRY, KM ;
FAUMAN, EB ;
FINERMOORE, JS ;
MALEY, GF ;
HARDY, L ;
MALEY, F ;
STROUD, RM .
BIOCHEMISTRY, 1990, 29 (30) :6964-6977
[55]   An alternative flavin-dependent mechanism for thymidylate synthesis [J].
Myllykallio, H ;
Lipowski, G ;
Leduc, D ;
Filee, J ;
Forterre, P ;
Liebl, U .
SCIENCE, 2002, 297 (5578) :105-107
[56]   Clinical significance of dihydropyrimidine dehydrogenase in adjuvant 5-fluorouracil liver perfusion chemotherapy for pancreatic cancer [J].
Nakayama, S ;
Takeda, S ;
Kawase, Y ;
Inoue, S ;
Kaneko, T ;
Nakao, A .
ANNALS OF SURGERY, 2004, 240 (05) :840-844
[57]   Phylogenetic classification of protozoa based on the structure of the linker domain in the bifunctional enzyme, dihydrofolate reductase-thymidylate synthase [J].
O'Neil, RH ;
Lilien, RH ;
Donald, BR ;
Stroud, RM ;
Anderson, AC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (52) :52980-52987
[58]  
OKSANA A, 2003, BIOCHEM BIOPH RES CO, V307, P297
[59]   METABOLISM AND MECHANISM OF ACTION OF 5-FLUOROURACIL [J].
PARKER, WB ;
CHENG, YC .
PHARMACOLOGY & THERAPEUTICS, 1990, 48 (03) :381-395
[60]  
PAWELCZAK K, 1993, CHEM BIOL PTERIDINES